Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

Summary

The poor survival of Veterans with oral cancer underscores the significance of identifying new treatment approaches. The proposed studies will test a new 2 pronged immunotherapeutic approach for oral cancer patients which lessen the immune inhibitory environment while maturing cells that can stimulate T cell reactivity against oral cancer cells.

Timeline

Start

2009-11

Primary completion

2015-12

Completion

2015-12

Drugs

Indications